Australia aims to complete review of Pfizer's COVID-19

Australia aims to complete review of Pfizer's COVID-19 vaccine by January 2021

WorldNews

Published 03 Dec 2020

SYDNEY (Reuters) - Australia's pharmaceutical regulator said on Thursday it is on course to review Pfizer's COVID-19 vaccine by January 2021, with the country sticking to a March timetable to start vaccinations. Read full story ......

Full Article

Australia aims to complete review of Pfizer's COVID-19 vaccine by January 2021

Australia aims to complete review of Pfizer's COVID-19 vaccine by January 2021

Advertisement

Related news coverage

Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.’s President, Dr. Anil Diwan

The Virus Doesn’t Know There’s A New US President – OpEd

NanoViricides, Inc.: Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.'s President, Dr. Anil Diwan

You might like

More coverage

5am-2021-01-19

010521 tues 11

WCBI NEWS AT TEN - DECEMBER 04, 2020

Respiratory Syncytial Virus Therapeutics Market worth USD 4,003.4 Million at 30.9% CAGR; Varying Ethnicity and Climate Difference to Boost Demand in Asia Pacific